Amoxicillin And Clavulanate Potassium Powder, For Suspension
Product Images NDC 71205-036

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 71205-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-036-12 (Amoxiclav Fig1)

71205-036-12 (Amoxiclav Fig1)
This is a description of a relabeled oral suspension medication containing amoxicillin and clavulanic acid. The medication comes in a 125mL bottle and each 5mL reconstituted suspension contains 600mg of amoxicillin trihydrate and 42.9mg clavulanic acid. The label gives instructions for storage and usage. The medication is produced by Aurobindo Pharma Limited in Hyderabad, India, and the original expiration date is not available.*
FDA Label Image

Amoxicillin Chemical Structure (Amoxiclav Str1)

FDA Label Image

Clavulanate Potassium Chemical Structure (Amoxiclav Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.